national clinical management protocol: Live & Latest News Updates : Vimarsana.com

AIIMS to Set Up AYUSH Academic Departments Across India: Secretary Rajesh Kotecha | Exclusive

In an interview to News18, AYUSH Ministry Secretary Rajesh Kotecha said the chain of AIIMS hospitals will now establish academic departments for the AYUSH system of medicines. He added that India is also working on creating a mechanism to claim patents on traditional medicines

Centre advises states to follow five-fold strategy amid Omicron scare

The Centre on Thursday advised states and UTs to not let their guard down and maintain their preparedness in fight against Covid pandemic and to follow five-fol

Centre asks States, UTs to ramp up vaccination, enforce containment measures

Research on Ayush Medicines to Curb Covid-19 Outbreak

Free distribution of homoeo medicine to prevent COVID-19

COVID-19 airborne, spreads when infected people cough, sneeze or talk: Centre

Highlights The Union Health Ministry revised its COVID-19 clinical management guidelines saying that the COVID-19 virus is airborne. It stated that the disease spreads when the infected person "coughs, sneezes or talks”. New Delhi: The Union Health Ministry on Wednesday revised its COVID-19 clinical management guidelines saying that the COVID-19 virus spreads “predominantly through the airborne route and droplet released when the infected person coughs, sneezes or talks”.  This a change from last year’s protocol which stated that “These droplets may also land on surfaces, where the virus has been seen to remain viable for a variable duration of time depending on the type of surface. Infection can also occur if a person touches an infected surface and then touches his or her eyes, nose, or mouth. (known as fomite transmission),” the Health Ministry’s National Clinical Management Protocol for COVID-19 stated.

Fainting can be Prevented by Slow Yoga

Fainting can be Prevented by Slow Yoga by Karishma Abhishek on  May 22, 2021 at 12:14 AM Guided yoga is more effective than conventional treatment for preventing fainting in repeat sufferers, as per a study published in EP Europace, a journal of the European Society of Cardiology (ESC).1 yoga therapy was also more beneficial in terms of quality of life than the standard treatment. "Vasovagal syncope" or fainting is characterized by a brief loss of consciousness due to reduced blood flow to the brain. Triggers like prolonged standing, fear, pain, seeing blood, and hot, humid environments can contribute to the event. Approximately half of the general population experience at least one syncopal event during their lifetime. Preventions like keeping hydrated, avoiding hot crowded environments, tensing the muscles, and lying down are recommended for it. However, only modest benefits have been reported with these methods.

Slay those symptoms: How some giloy can help amid COVID-19

Free Ayush-64 drug for positive patients

Free Ayush-64 drug for positive patients Free Ayush-64 drug for positive patients BySupriya DedgaonkarSupriya Dedgaonkar / Updated: May 13, 2021, 06:00 IST Distribution of the kits will be done from today; ideal for those with mild to moderate symptoms In order to help COVID-19 patients with mild and moderate symptoms, the availability of Ayush-64, an ayurvedic medicine approved by the Centre, will be in place from Thursday onwards. Several citizens across the city with such symptoms can avail this free of cost. The Union government has announced free distribution of Ayush-64 kits at National Institute of Naturopathy in the city from Thursday. This particular announcement is made at a time when the nation is dealing with a massive surge in COVID-19 cases. The same will be available free of cost between 10 am and 5 pm.

Study backs Ayurvedic drug Ayush 64 in for treatment of mild to moderate Covid-19 infection

Industry > Industry monitor > Healthcare 29 April 2021 Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care. Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collaborated for robust multi-centre clinical trials to evaluate the safety and efficacy of Ayush 64 in the management of mild to moderate Covid-19 patients. Clinical trials were conducted at KGMU, Lucknow; DMIMS, Wardha and BMC Covid Centre, Mumbai, involving 70 participants in each arm. Dr Chopra said Ayush 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalisation compared to the only SoC procedure, Dr Arvind Chopra, director, Centre for Rheumatic Diseases, Pune and honorary chief clinical coordinator of the ministry of Ayush- CSIR collaboration, informed.